A systematic review and meta-analysis on the risk factors of acute myeloid leukemia

被引:12
|
作者
Guo, Yanrong [1 ]
Wang, Wenwen [1 ]
Sun, Huali [2 ]
机构
[1] Taizhou Cent Hosp, Dept Hematol, Taizhou Univ Hosp, Taizhou, Peoples R China
[2] Taizhou Cent Hosp, Radiotherapy Sect, Taizhou Univ Hosp, 999,Donghai Ave, Taizhou, Peoples R China
关键词
Acute myeloid leukemia (AML); family tumor history; hepatitis B virus infection rate (HBV infection rate); hepatitis C virus infection rate (HCV infection rate); environmental exposure rate; CHILDHOOD ACUTE-LEUKEMIA; FAMILY-HISTORY; HEPATITIS-B; CANCER; EXPOSURE; CHILDREN;
D O I
10.21037/tcr-22-27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Acute myeloid leukemia (AML) is one of the main types of leukemia that threatens the life and health of patients. A large number of clinical studies have been conducted on the etiology of the disease. However, there are few evidence-based medical studies and no definitive treatment guidelines. Methods: Related articles were searched from Medline, Excerpta Medica Database (EMBASE), EBSCO, OVID, Chinese Biology Medicine Disc (CBMDISC), and Wanfang databases. The search time limit was from the establishment of the database to September 2021. The search terms were as follows: acute myeloid leukemia, AML, electromagnetic field, case-control study, cohort study, and risk factors. All literatures were included according to PICOS standards, and the risk of deviation and literature quality were assessed. RevMan 5.3 software was used for meta-analysis. Results: The 10 articles included were of high quality and low bias risk. The research results showed that compared with healthy people, among the risk factors for AML, family tumor history [risk ratio (RR) =0.98; 95% confidence interval (CI): (0.57, 1.69); Z=0.08; P=0.94] and the hepatitis B virus (HBV) infection rate [odds ratio (OR) =1.34; 95% CI: (0.57, 3.13); Z=0.68; P=0.50] showed no significant differences, but the hepatitis C virus (HCV) infection rate [OR =1.60; 95% CI: (1.17, 2.19); Z=2.92; P=0.003] and environmental exposure rate [OR =1.49; 95% CI: (1.01, 2.21); Z=2.02; P=0.04] increased significantly. Conclusions: A total of 10 articles were included to analyze AML risk factors and related content. The results suggested that HCV infection and environmental exposure history such as home decoration were risk factors for AML.
引用
收藏
页码:796 / 804
页数:9
相关论文
共 50 条
  • [41] Risk Factors of Acute Kidney Injury in ECMO Patients: A Systematic Review and Meta-Analysis
    Mou, Zhixiang
    Guan, Tianjun
    Chen, Lan
    JOURNAL OF INTENSIVE CARE MEDICINE, 2022, 37 (02) : 267 - 277
  • [42] Risk Factors for Acute Endophthalmitis following Cataract Surgery: A Systematic Review and Meta-Analysis
    Cao, He
    Zhang, Lu
    Li, Liping
    Lo, SingKai
    PLOS ONE, 2013, 8 (08):
  • [43] Association between MTHFR Polymorphisms and Acute Myeloid Leukemia Risk: A Meta-Analysis
    Qin, Yu-Tao
    Zhang, Yong
    Wu, Fang
    Su, Yan
    Lu, Ge-Ning
    Wang, Ren-Sheng
    PLOS ONE, 2014, 9 (02):
  • [44] Artificial intelligence for the detection of acute myeloid leukemia from microscopic blood images; a systematic review and meta-analysis
    Al-Obeidat, Feras
    Hafez, Wael
    Rashid, Asrar
    Jallo, Mahir Khalil
    Gador, Munier
    Cherrez-Ojeda, Ivan
    Simancas-Racines, Daniel
    FRONTIERS IN BIG DATA, 2025, 7
  • [45] Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis
    Costa, A. F. O.
    Menezes, D. L.
    Pinheiro, L. H. S.
    Sandes, A. F.
    Nunes, M. A. P.
    Lyra Junior, D. P.
    Schimieguel, D. M.
    SCIENTIFIC REPORTS, 2017, 7
  • [46] Efficacy and safety of venetoclax combination therapy for relapsed/refractory acute myeloid leukemia: a systematic review and meta-analysis
    Jiao, Ning
    Shi, Lina
    Wang, Shaohua
    Sun, Yonghao
    Bai, Yujun
    Zhang, Dengshan
    BMC CANCER, 2024, 24 (01)
  • [47] Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis
    A. F. O. Costa
    D. L. Menezes
    L. H. S. Pinheiro
    A. F. Sandes
    M. A. P. Nunes
    D. P. Lyra Junior
    D. M. Schimieguel
    Scientific Reports, 7
  • [48] Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis
    Cao, Susu
    Tao, Qianshan
    Wang, Jia
    Zhang, Qing
    Dong, Yi
    MEDICINE, 2023, 102 (44) : E34949
  • [49] Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia
    Franco, Stephanie
    Geng, Xue
    Korostyshevskiy, Valeriy
    Karp, Judith E.
    Lai, Catherine
    CANCER, 2023, 129 (19) : 2975 - 2985
  • [50] Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis
    Mingzhu Song
    Huiping Wang
    Qianling Ye
    Systematic Reviews, 9